• Emerge
  • Posts
  • 🚀 Uber revenues rise

🚀 Uber revenues rise

Market Overview
Read time 1.4 minutes

Year To Date Performances:

Dow Jones  48,892.47 1.73%
S&P 500  6,939.03 1.37%
Nasdaq  23,461.82 0.95%
Russell 2000 2,613.74 5.31%
TSX  31,923.52 0.66%
Bitcoin $77,929.85 -12.26%
Ethereum $2,297.84 -21.71%
US to Canadian Dollar $1.36 -0.62%
  1. Uber’s final quarter of 2025 painted a picture of a company successfully leaning into its dual-engine growth model, with a record $14.37 billion in revenue driven largely by a 30% surge in its delivery business. While the ride-hailing segment remains the primary breadwinner at $8.2 billion, the "Dine Out" initiative and deep-stack integrations with Shopify and OpenTable have transformed Uber Eats from a pandemic-era lifeline into a permanent high-margin retail powerhouse. However, the stock’s pre-market dip reflects investor unease over a non-GAAP earnings miss—reporting $0.71 per share against a $0.80 whisper number—and a massive $1.6 billion headwind from equity revaluations. Despite the cooling share price, the company is seeing significant macro tailwinds from the "One Big Beautiful Bill" (OBBB) tax provisions, which have stabilized the courier workforce through the federal "no tax on tips" deduction. Looking forward, the recent debut of the Lucid-Nuro robotaxi at CES 2026 and the aggressive target of 15 autonomous cities by year-end suggest that CEO Dara Khosrowshahi is no longer just managing a logistics company, but is instead racing to own the digital infrastructure for the entire multitrillion-dollar mobility-as-a-service ecosystem.

  2. Eli Lilly has delivered a staggering fourth-quarter performance that effectively solidifies its position as the dominant force in the global metabolic health market. The pharmaceutical giant reported revenue of $19.29 billion, a 43% increase year-over-year, which handily outpaced Wall Street estimates. This growth was fueled by the explosive adoption of Mounjaro and Zepbound, which saw combined quarterly sales exceeding $11.6 billion. Unlike its primary rival Novo Nordisk, which recently issued a bleak outlook citing pricing pressures, Lilly provided a robust 2026 revenue guidance of $80 billion to $83 billion. This optimistic forecast is bolstered by the landmark pricing agreement reached with the Trump administration, which trades lower per-unit costs for a massive expansion in volume through new Medicare coverage and the launch of the TrumpRx direct-to-consumer platform.

  3. The American housing market is grappling with a significant "rate rift" as the share of homeowners with mortgages above 5% has tripled to more than 30% in just four years, according to new data from ICE Mortgage Technology. While the pandemic era was defined by record-low sub-3% rates, more recent buyers and those seeking cash-out equity have pushed approximately 20% of all borrowers into the 6%-plus territory, effectively stalling the resale market as existing owners refuse to surrender their "golden handcuffs." To combat this "lock-in" effect, the Trump administration has signaled a massive $200 billion intervention through Fannie Mae and Freddie Mac bond purchases, a move intended to force the 30-year fixed rate down toward 6.0%. If successful, this maneuver could trigger a refinancing wave for 5.5 million households, though experts warn that the actual monthly savings for new buyers—roughly $35 for an average home—may not be the silver bullet needed to revitalize a market that has seen sales languish at a historic low of 4.06 million units.

    Headlines

    1. Pinterest has fired an employee who was tracking layoffs.

    2. Private payrolls grew by 22,000 in January, less than expected.